Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

A new fund is providing up to $5,000 to Boston families who have an immediate family member who died from an opioid overdose.

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Mr. Agather writes Jan. 23, “I hate to see stupidity rewarded.” As for me, I hate to see false and misleading claims rewarded. Hurricane-force winds and extraordinarily dry conditions were the prime ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

Opioid abuse tells a tragic American story since avoidable deaths began in the 1990s. Nearly 700,000 people lost their lives to overdoses of OxyContin and offshoots of the highly addictive ...

Opioid abuse tells a tragic American story since avoidable deaths began in the 1990s. Nearly 700,000 people lost their lives ...

The money could benefit the 14 syringe service programs across the five boroughs that offer harm reduction services.

This month’s KELOLAND Living Book Club selection examines the history of the Sackler family, including the founding of Purdue Pharma, its role in the marketing of pharmaceuticals, and the ...